Interestingly, clinical data show that PLK4 and AURKB expression are increased in high-grade bladder cancer (Supplementary Fig. 3i) and correlate with reduced survival in breast cancer patients (Supplementary Fig. 3h). This evidence concerns the gene PLK4 and urinary bladder cancer.